Navigation Links
Vestaron Corporation Announces New Leadership
Date:4/28/2011

KALAMAZOO, Mich., April 28, 2011 /PRNewswire/ -- Vestaron Corporation, a Kalamazoo-based company developing the next- generation of environmentally conscious insecticide products, announced today that John Sorenson, Ph.D., will serve as interim President and Chief Executive Officer. The Board of Directors thanks John McIntyre for his years of service leading to the development of breakthrough insecticides for agriculture.

"John's scientific leadership has been just what Vestaron needed to get us to where we are today," said Jim Schultz of Open Prairie Ventures, a major investor and board director. "We wish John well in his next endeavor."

John Sorenson, Ph.D., will serve as interim President and CEO and continue his current role as Chairman of the Board of Directors. Elin Miller will continue her role as Vice Chairman while the company searches for a new CEO. Vestaron has engaged Kincannon & Reed for the search, which has already begun.

"This is a critical and exciting time for our company with upcoming field trials this summer, which will set the stage for our registration submission. I am thrilled to take the helm," said Dr. Sorenson. Dr. Sorenson has a broad background in plant biotechnology, both in academe and in the private sector. In addition to serving as President of Biotechnology for Syngenta, he also served as President of Syngenta Seed, Inc. and held several positions in the Asgrow Seed Company. Sorenson began his career as Assistant and Associate Professor of Genetics at North Carolina State University.

Vestaron Corporation is a Kalamazoo, Mich.-based company that has been working for the past few years to develop insecticide products that are harmless to humans and other mammals and are environmentally conscious. Using the polypeptides found in spider venom, Vestaron which was formerly known as Venomix, Inc., has reported that its tests are seeing positive results against mosquitoes, caterpillars, flies and cockroaches.

Vestaron Corporation is a portfolio company of Open Prairie Ventures, an Effingham, Illinois- based venture capital firm with offices in Kalamazoo and Southwest Michigan First Life Science Fund.


'/>"/>
SOURCE Vestaron Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
2. Every Day is Earth Day for Yulex Corporation
3. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
4. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
5. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
6. Techne Corporation Announces Acquisition
7. Ther-Rx Corporation Commits to Take Action Regarding Makena™ Pricing
8. SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. Volcano Corporation Presentation at Roth Capital Conference to be Webcast
11. Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) announced ... CEO and Fabrice Orecchioni, the company,s COO, has been named President, ... the past four years, Fabrice has overseen the construction, start-up and ... and the management of the Mitsui JV.  Fabrice has also been ... China JV. ...
(Date:2/20/2017)... ... 20, 2017 , ... Salford-based Mettler Toledo Safeline, which employs ... processing and packaging industries, was runner-up for the Environmental Achievement Award, sponsored by ... or taken the most innovative steps to improve its environmental performance. , ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... among radiotherapy patients, prevent chest wall collapses in pre-term infants with respiratory ... receive a total of $600,000 in funding through the ninth round of ...
(Date:2/20/2017)... , Feb. 20, 2017  At the ... in Orlando , IBM (NYSE: ... collaborators and clients. IBM Chairman, President and CEO ... opening keynote address today from 8:30-10 am ET, ... , and ibm.com/industries/healthcare. Her remarks examine the advent ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):